Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

David Beasley, Li Li, Miguel T. Suderman, Farshad Guirakhoo, Dennis W. Trent, Thomas P. Monath, Robert E. Shope, Alan Barrett

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX®, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX® control.

Original languageEnglish (US)
Pages (from-to)3722-3726
Number of pages5
JournalVaccine
Volume22
Issue number27-28
DOIs
StatePublished - Sep 9 2004

Fingerprint

Japanese Encephalitis Virus
Japanese encephalitis virus
blood serum
Vaccines
Genotype
vaccines
genotype
Serum
neutralization tests
antiserum
Immune Sera
mice
ChimeriVax

Keywords

  • ChimeriVax™-JE
  • Genotype
  • Japanese encephalitis virus

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine. / Beasley, David; Li, Li; Suderman, Miguel T.; Guirakhoo, Farshad; Trent, Dennis W.; Monath, Thomas P.; Shope, Robert E.; Barrett, Alan.

In: Vaccine, Vol. 22, No. 27-28, 09.09.2004, p. 3722-3726.

Research output: Contribution to journalArticle

Beasley, David ; Li, Li ; Suderman, Miguel T. ; Guirakhoo, Farshad ; Trent, Dennis W. ; Monath, Thomas P. ; Shope, Robert E. ; Barrett, Alan. / Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine. In: Vaccine. 2004 ; Vol. 22, No. 27-28. pp. 3722-3726.
@article{b11a8e5b5eeb43c88b78334511b1f827,
title = "Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine",
abstract = "The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX{\circledR}, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX{\circledR} control.",
keywords = "ChimeriVax™-JE, Genotype, Japanese encephalitis virus",
author = "David Beasley and Li Li and Suderman, {Miguel T.} and Farshad Guirakhoo and Trent, {Dennis W.} and Monath, {Thomas P.} and Shope, {Robert E.} and Alan Barrett",
year = "2004",
month = "9",
day = "9",
doi = "10.1016/j.vaccine.2004.03.027",
language = "English (US)",
volume = "22",
pages = "3722--3726",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "27-28",

}

TY - JOUR

T1 - Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

AU - Beasley, David

AU - Li, Li

AU - Suderman, Miguel T.

AU - Guirakhoo, Farshad

AU - Trent, Dennis W.

AU - Monath, Thomas P.

AU - Shope, Robert E.

AU - Barrett, Alan

PY - 2004/9/9

Y1 - 2004/9/9

N2 - The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX®, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX® control.

AB - The ability of antisera raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax™-JE, and the currently licensed vaccine, JE-VAX®, to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. ChimeriVax™-JE stimulated protection that was comparable or superior to the JE-VAX® control.

KW - ChimeriVax™-JE

KW - Genotype

KW - Japanese encephalitis virus

UR - http://www.scopus.com/inward/record.url?scp=4143125552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143125552&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2004.03.027

DO - 10.1016/j.vaccine.2004.03.027

M3 - Article

C2 - 15315852

AN - SCOPUS:4143125552

VL - 22

SP - 3722

EP - 3726

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 27-28

ER -